Search
Memorial Sloan Kettering Cancer Center (MSK) is partnering with DigitasLBi and Phase2 to help expand MSK's digital reach.
Memorial Sloan Kettering and Quest Diagnostics announced a joint collaboration that will utilize MSK’s clinical and research insights into gene mutations associated with solid tumors.
Learn about some of the most important clinical advances made at MSK in 2021.
Long-awaited results of clinical trials testing targeted drugs and immunotherapy combinations were on offer at the annual American Association for Cancer Research (AACR) conference.
The David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center will be home to the largest gathering of hematologic experts ever at Memorial Sloan Kettering Cancer Center (MSK), including specialists in blood and marrow stem cell transplants, chimeric antigen receptor T cell therapy, lymphoma, leukemia, multiple myeloma, and nonmalignant blood disorders.
The 2023 GSK Chairman’s Prize recognizes Chi Nguyen for research on gut health.
New data from researchers at Memorial Sloan Kettering Cancer Center (MSK) revealed the effects of Medicaid expansion on cancer death rates on a national scale.
MSK investigators are leading the way with approaches so bold they are like the difference between "a snapshot and a movie."
Experts at MSK’s Center for Young Onset Colorectal and Gastrointestinal Cancer are devoted to creating the best treatment plan for you and your family.
A protein in the body that protects against viruses can also cause cancer-related mutations.